This year, World No Tobacco Day is on May 31, 2018 and the emphasis will be on tobacco and heart disease. 1 Despite progress that has been made in public health measures to combat smoking, the still increasing world population means the numbers smoking are still at pandemic proportions. Higher income countries in our region are decreasing smoking rates, but the multinational corporations have shifted the promotion of cigarettes to low-and middle-income countries. In the APACPH (Asia Pacific Academic Consortium for Public Health) member countries, smoking rates vary widely. In males older than 18 years in Australia and New Zealand, the rates are about 18% while in Kiribati the rate is 65%, China 43%, Japan 30%, and Indonesia 65%, with highest rate in Timor-Leste at 70%. 2 Currently, around 1 billion persons smoke, killing more than 7 million people a year. More than 6 million of those deaths are the result of direct tobacco use while around 890 000 are the result of nonsmokers being exposed to secondhand smoke. The huge death toll from tobacco makes the epidemic one of the biggest public health threats the world has ever faced. 1 The most common pathology is ischemic heart disease and stroke, except in lower income countries where lower respiratory disease is number one. Approximately 80% of all deaths from chronic obstructive pulmonary disease (COPD) are caused by smoking with 90% occurring in low-and middle-income countries. It has been estimated that COPD will be the third leading cause of death worldwide in 2030.
It is likely that the risk for women of smoking low numbers of cigarettes (1-5 per day) is even higher. Thus, even if risk of e-cigarettes is lower (and there are no long-term studies yet), there is a strong likelihood that they will still cause substantial numbers of cardiovascular events.
The global cigarette market today has multibillion dollar sales and profits and according to IMARC group, its total revenues reached $US 816 billion in 2016, with a growth of approximately 7% annually between 2009 and 2016. 4 To preserve profits, and perhaps even increase them, the multinational companies are increasing investment in e-cigarettes and vaping. 5 They seem to be succeeding by enticing a new group of young adults to risk nicotine addiction. In the United States, a report from the US Surgeon General, found a 900% increase in e-cigarette use by high school students from 2011 to 2015, with 1.7 million high school students using e-cigarettes in the previous 30 days. 6 It appears that new products are being tailored at women and children.
On February 1, 2018, Singapore became the first country to ban the use or possession of equipment for vaping (electronic cigarettes). Several Australian states are likely to follow suit in the near future. At the same time, the Singapore Ministry of Health released a discussion paper for the future directions of tobacco control in their country. 7 They propose to introduce plain packaging of cigarettes following the example of Australia and more recently, the United Kingdom, New Zealand, France, and Norway, and the list is growing. It is a measure that is strongly opposed by the tobacco industry who have spent many millions fighting the legislation because of its proven effectiveness. 8 Singapore is a good example of effective public health tobacco policy for the rest of the APACPH countries to follow.
The Deans of Schools of Public Health in the United States have joined together to ban research funding from the Foundation for a Smoke Free World, which is a tobacco industry front to promote research that will not damage tobacco interests. 9 The funding for this foundation includes an initial commitment of $1 billion from the Phillip Morris Company. 10, 11 This probably accounts for less than $10 for every citizen who has died from smoking their cigarettes. As the Lancet editorial states, Many, with good reason, view the interests of tobacco companies as fundamentally irreconcilable with public health. If the tobacco industry was truly sincere about its desire for a smoke-free world, it would stop its opposition to measures proven to reduce smoking rates, such as advertising bans, tax increases, plain packaging, and health warnings. It would cease all manufacturing, marketing, lobbying, and litigation activities. Critics have also suggested that harm reduction is the wrong public health approach for smoking cessation because it undermines efforts to stop people, especially younger people, from taking up smoking.
It's just over 50 years ago that expert reports on the health dangers of smoking were released. 12 But just a few years before that doctors and other health professionals were actually endorsing cigarettes and cigars because of their "health" benefits as seen in this series of vintage advertisements. 13 We wonder if today's health professionals and health organizations who are suggesting that e-cigarettes may be a way of harm reduction in the future may live to regret their words.
What can APACPH do? We are still surprised to find that on the campuses of some universities and schools of public health that smoking and vaping is still permitted. This undermines the exemplar role of public health professionals. We need to set a good example to society and completely ban tobacco, e-cigarettes and vaping from our campuses. This needs our immediate action as we provide an example to the rest of society as to what a healthy community should be like. We also need to ensure that the tobacco industry is not able to fund research on our campuses directly or through a front organization. APACPH should follow the example of the United States where the Deans of Schools of Public Health have banned any research funding from the Foundation for a Smoke Free World. 11 For our part, the APJPH will not publish any research funded by this or any other tobacco industry-funded foundation.
In this month's journal issue, we include an original article on e-cigarettes from Korea and an article on indoor air pollution from China. In addition, there are several commentaries on vaping or e-cigarettes. We welcome further evidence-based discussion of these issues through letters to the editor or original research papers.
